Thermodynamic Control of Lamivudine Form I Crystallization

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Existing methods for producing Form I lamivudine are often kinetically controlled, leading to variability in crystal form across lots and production scales, resulting in potential contamination with Form II.

Innovation Solution

A thermodynamically controlled process for crystallizing Form I lamivudine, maintaining specific temperature and water activity conditions to ensure stability and minimize contamination with other forms, using a solvent system comprising water and an organic solvent, optionally with a base and seed, to produce a crystalline product substantially free of other forms.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If kinetically controlled crystallization is used to produce Form I lamivudine, then the crystallization process can be completed, but variability in crystal form across lots and production scales occurs and contamination with Form II is possible

Engineering Contradiction:

Improvecrystallization process completionVSAvoidconsistency of crystal form

Core Design Contradiction:

ProductivityVSReliability

Solution Approach 1:

The patent changes the fundamental parameter of crystallization control from kinetic to thermodynamic by adjusting temperature and solvent composition to specific ranges where Form I is the thermodynamically stable polymorph. This ensures that regardless of crystallization rate or mixing conditions, the system naturally favors Form I formation, eliminating variability across lots and scales while preventing Form II contamination.

Inventive Principle:

Principle #35Parameter changes

2Ease of operation

If kinetically controlled crystallization is used, then crystallization can proceed at various rates, but contamination with Form II and variability in crystal form increases

Engineering Contradiction:

Improveflexibility in crystallization rateVSAvoidpurity of crystal form

Core Design Contradiction:

Ease of operationVSManufacturing precision

Solution Approach 1:

The patent establishes specific parameter ranges for temperature (0-50°C) and solvent composition (water-organic solvent mixtures with defined water activity ranges) where Form I is thermodynamically stable. Within these ranges, the crystallization rate can vary without affecting product purity, as the thermodynamic stability ensures Form I formation regardless of kinetic conditions.

Inventive Principle:

Principle #35Parameter changes

3Reliability

If thermodynamically controlled crystallization is implemented, then Form I stability and purity are ensured, but process conditions must be precisely maintained

Engineering Contradiction:

Improvestability and purity of Form IVSAvoidprocess control requirements

Core Design Contradiction:

ReliabilityVSDevice complexity

Solution Approach 1:

The patent defines broad but specific parameter ranges for temperature (0-50°C) and water activity (0.60-0.80) where Form I is thermodynamically stable. These ranges provide sufficient control precision to ensure reliability without requiring overly complex process control systems, as the thermodynamic stability window is sufficiently wide to accommodate normal process variations.

Inventive Principle:

Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This process ensures the production of Form I lamivudine that is consistently stable and free of other forms, reducing variability and contamination, thereby enhancing the reliability and scalability of the crystallization method.

Implementation Method 1

maintaining specific temperature and water activity conditions to ensure stability

Methodology Applied

Scientific EffectWater activity control:

Implementation Method 2

crystallizing Form I at a temperature T of from about 0° C. to about 50° C. from a mixture which comprises (a) lamivudine or an acid salt thereof or both

Methodology Applied

Scientific EffectCrystallization: Crystallisation

Data Source

PatentUS8796452B2Preparation of lamivudine form I

Publication Date: 2014.08.05 MERCK SHARP & DOHME LLC

AI summary

A thermodynamically controlled process for preparing Form I polymorph of lamivudine is described, wherein the process involves crystallizing Form I at a temperature of from about 0° C. to about 50° C. from a mixture which comprises (a) lamivudine or an acid salt thereof or both, (b) a solvent system comprising water and at least one organic solvent, and optionally (c) Form I seed; wherein, when a lamivudine acid salt is employed in the mixture, the crystallizing step is conducted in the presence of a base; and wherein the water activity of the solvent system is maintained in a range in which Form I is thermodynamically the most stable form of lamivudine.